127 results on '"Mirabito Colafella, Katrina M."'
Search Results
2. Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
3. A roadmap of strategies to support cardiovascular researchers: from policy to practice
4. Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease
5. Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment
6. Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia
7. Antihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension
8. Interference With the Renin–Angiotensin System (RAS): Classical Inhibitors and Novel Approaches
9. Highlights from the International Society of Hypertensionʼs New Investigators Network during 2019
10. Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen
11. Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
12. Abstract P068: Dietary Sodium Restriction Prevents Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension
13. Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen
14. Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
15. Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
16. Angiotensinogen Suppression:A New Tool to Treat Cardiovascular and Renal Disease
17. Strategies to support early- and mid-career cardiovascular researchers to thrive
18. Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats
19. Abstract 05: Cyclooxygenase-2 Inhibition As A New Tool To Combat Angiogenesis Inhibitor-induced Hypertension And Renal Toxicity
20. In Aged Females, the Enhanced Pressor Response to Angiotensin II Is Attenuated By Estrogen Replacement via an Angiotensin Type 2 Receptor-Mediated Mechanism
21. Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?
22. The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
23. The effect of age on blood pressure response by 4-week treatment perindopril:A pooled sex-specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
24. Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia
25. Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in Australia
26. No evidence for brain renin–angiotensin system activation during DOCA-salt hypertension
27. Insulin-regulated aminopeptidase deficiency impairs cardiovascular adaptations and placental development during pregnancy
28. Salt-sensitive hypertension in chronic kidney disease: distal tubular mechanisms
29. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats
30. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis
31. Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
32. Abstract P2031: Control Of Antihypertensive Effect Of Small Interfering RNA Targeting Angiotensinogen
33. The renin-angiotensin-aldosterone system and its therapeutic targets
34. Abstract P2030: DOCA-Salt Diminishes Brain RAS Activity In Parallel With Plasma And Renal RAS Activity - No Evidence For Selective Brain RAS Activation
35. Placental effects and transfer of sildenafil in healthy and preeclamptic conditions
36. Endothelin receptor antagonism during preeclampsia: a matter of timing?
37. Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
38. Sunitinib-induced blood pressure rise does not involve aldosterone
39. Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
40. Abstract P110: Renal Angiotensin Generation Depends on Hepatic Angiotensinogen: Evidence From a Preclinical Study With RNAi Therapeutics Targeting Liver Angiotensinogen
41. Abstract 079: Long-Lasting RNAi Therapeutics Targeting Angiotensinogen Induces a Robust and Durable Antihypertensive Effect
42. Abstract P149: VEGF Inhibitor-Induced Hypertension and Renal Injury: Prevention by Aspirin?
43. Abstract 043: Targeting the Angiotensin Type 2 Receptor With Relaxin Confers Protection Against Renal Fibrosis and Vascular Dysfunction in Female Stroke Prone-Spontaneously Hypertensive Rats
44. Endothelin type B (ETB) receptors: friend or foe in the pathogenesis of pre-eclampsia and future cardiovascular disease (CVD) risk?
45. Relaxin contributes to the regulation of arterial pressure in adult female mice
46. Abstract P186: Selective ET A Receptor Antagonism versus Dual ET A /ET B Receptor Blockade for Preventing Angiogenesis Inhibitor-induced Hypertension
47. Abstract 052: Chronic Angiotensin Type 2 Receptor Stimulation Abolishes the Sex-difference in Ang II-induced Hypertension
48. Abstract 045: The Enhanced Pressor Response to AngII in Aged Females is Attenuated by Estrogen Replacement via an AT 2 R-mediated Mechanism
49. Recent Advances in Angiotensin Research
50. The protective effect of apolipoprotein in models of trophoblast invasion and preeclampsia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.